Mucopolysaccharidosis Type III (Sanfilippo Syndrome): Developing Drugs for Treatment Guidance for Industry: Draft Guidance for Industy
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
February 4, 2020
May 14, 2020
942f35fd-9db0-4292-9bf9-3ebc347373df
Related Documents
Treatment for Heart Failure: Endpoints for Drug Development Guidance for Industry
Guidance DocumentJune 28, 2019Center for Drug Evaluation and Research
Neovascular Age-Related Macular Degeneration: Developing Drugs for Treatment
Guidance DocumentFebruary 24, 2023Center for Drug Evaluation and Research
Fabry Disease: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentAugust 7, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.